Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
iSelect Fund
AddedFeb 13, 2024
UpdatedJun 28, 2026
iSelect Fund

iSelect Fund

Operating

iSelect Fund: A venture firm investing in solutions for critical global issues with profitable models.

Location
St. Louis, MO, US
Founded
2013
Firm
Compare
Portfolio
Fundraising
Employees
Website

iSelect Fund focuses on investing in companies addressing critical global issues, particularly at the intersection of AgTech and human health. The firm targets solutions for soil and crop health, sustainable protein production, food nutrition and affordability, and farmer profitability. In healthcare, iSelect invests in data analysis and delivery technologies for early detection, intervention, and treatment.

Notable portfolio companies include Benson Hill, Brightseed, and Vestaron. iSelect's investments span various stages, from seed to Series C, with a concentration on Series A rounds. The firm's approach emphasizes financially attractive business models in large markets, aiming to support innovations that can make a significant impact on global challenges while delivering strong returns.

iSelect Fund - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments62
Current Portfolio Count38
Total Portfolio Exits0

Top Investment Stages

Series A17 (31.5%)
Seed11 (20.4%)
Series Unknown11 (20.4%)
Series B9 (16.7%)
Series C6 (11.1%)

Stage Mix

Series A 31%Seed 20%Series Unknown 20%Series B 17%Series C 11%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Triplebar logo

Triplebar

PreventScripts logo

PreventScripts

Mend Nutrition logo

Mend Nutrition

Flywheel logo

Flywheel

Pluton Biosciences logo

Pluton Biosciences

Harpe Bio logo

Harpe Bio

Mercy BioAnalytics logo

Mercy BioAnalytics

Growers Edge logo

Growers Edge

EarthOptics logo

EarthOptics

Bond Pet Foods logo

Bond Pet Foods

Vestaron logo

Vestaron

Pattern logo

Pattern

Brightseed logo

Brightseed

one.bio logo

one.bio

Immunophotonics logo

Immunophotonics

Molecular Assemblies logo

Molecular Assemblies

Kula Bio logo

Kula Bio

Cyrus Biotechnology logo

Cyrus Biotechnology

Sentera logo

Sentera

Stony Creek Colors logo

Stony Creek Colors

Benson Hill logo

Benson Hill

TradeLanes logo

TradeLanes

Journeys Metabolic logo

Journeys Metabolic

Mobilion Systems logo

Mobilion Systems

HerdDogg logo

HerdDogg

iSelect Fund - Similar Investment Firms

AgFunder logo

AgFunder

agfunder.com

Investeco Capital logo

Investeco Capital

investeco.com

Germin8 Ventures logo

Germin8 Ventures

iSeed Ventures logo

iSeed Ventures

iseedvc.com

Narrative Fund logo

Narrative Fund

Seae Ventures logo

Seae Ventures

S2G Ventures logo

S2G Ventures

s2gventures.com

AllerFund logo

AllerFund

allerfund.com

ASW Venture Partners logo

ASW Venture Partners

Investor's Circle logo

Investor's Circle

SeedFolio logo

SeedFolio

Beta Fund logo

Beta Fund

Joyful Ventures logo

Joyful Ventures

joyful.vc

Harvest Returns logo

Harvest Returns

harvestreturns.com

Almanac logo

Almanac

iSelect Fund - Classification

Also Known As
  • Iselectfund Management, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end